Acyclovir Should Not Be Approved for Marketing Without Prescription
- 1 May 1996
- journal article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 23 (3) , 171-173
- https://doi.org/10.1097/00007435-199605000-00001
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Suppression of Subclinical Shedding of Herpes Simplex Virus Type 2 with AcyclovirAnnals of Internal Medicine, 1996
- Disseminated Acyclovir-Resistant Herpes Simplex Virus Type 2 Treated Successfully with FoscarnetThe Journal of Infectious Diseases, 1995
- Recurrence and Resistance Patterns of Herpes Simplex Virus following Cessation of >=6 Years of Chronic Suppression with AcyclovirThe Journal of Infectious Diseases, 1994
- Recurrent Acyclovir-Resistant Genital Herpes in an Immunocompetent PatientNew England Journal of Medicine, 1993
- Herpes RevisitedSexually Transmitted Diseases, 1993
- Acyclovir-Resistant Herpes Simplex Virus Infections in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989